In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Statistical parametric maps in functional imaging: A general linear approach

Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688 · see citing works

Microglia: a sensor for pathological events in the CNS

Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · see citing works

The FAB: A frontal assessment battery at bedside

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913 · see citing works

Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Simplified Reference Tissue Model for PET Receptor Studies

Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,025 · see citing works

Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations

Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673 · see citing works

Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe

Hammers, A., Allom, R. J., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,270 · see citing works

Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model

Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,085 · see citing works

In-vivo measurement of activated microglia in dementia

Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · see citing works

Microglial activation and dopamine terminal loss in early Parkinson's disease

Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 846 · see citing works

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · see citing works

Automated three‐dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures

Studholme, C., Hill, D., & Hawkes, D. J. (1997) · Medical Physics · doi:10.1118/1.598130 · Cited by 675 · see citing works

The peripheral benzodiazepine binding site in the brain in multiple sclerosis

Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661 · see citing works

Parkinson's Disease Society Brain Bank, London: overview and research.

Daniel, S. E., & Lees, A. J. (1993) · PubMed · Cited by 598 · see citing works

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET

Morrish, P., Rakshi, J. S., Bailey, D. L., Sawle, G. V., & Brooks, D. J. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.314 · Cited by 509 · see citing works

Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration

McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400 · see citing works

An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease

Morrish, P., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366 · see citing works

Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough

Lang, A. E., & Obeso, J. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00740-9 · Cited by 346 · see citing works

PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia

Banati, R. B., Myers, R., & Kreutzberg, G. W. (1997) · Journal of Neurocytology · doi:10.1023/a:1018567510105 · Cited by 299 · see citing works

Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study

Gerhard, A., Schwarz, J., Myers, R., Wise, R. J. S., & Banati, R. B. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.09.034 · Cited by 286 · see citing works

Pathogenic role of glial cells in Parkinson's disease

Teismann, P., Tieu, K., Cohen, O. S., Choi, D., Wu, D. C., Marks, D., Vila, M., Jackson-Lewis, V. R., & Przedborski, S. (2002) · Movement Disorders · doi:10.1002/mds.10332 · Cited by 272 · see citing works

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study

Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J. (1999) · Brain · doi:10.1093/brain/122.9.1637 · Cited by 269 · see citing works

THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSON'S DISEASE, STUDIED WITH PET

Brooks, D. J., Salmon, É., Mathias, C. J., Quinn, N. P., Leenders, K. L., Bannister, R., MARSDEN, C. D., & Frackowiak, R. S. J. (1990) · Brain · doi:10.1093/brain/113.5.1539 · Cited by 256 · see citing works

Thalamic microglial activation in ischemic stroke detected in vivo by PET and [ 11 C]PK11195

Pappatà, S., Levasseur, M., Gunn, R. N., Myers, R., Crouzel, C., Syrota, A., Jones, T., Kreutzberg, G. W., & Banati, R. B. (2000) · Neurology · doi:10.1212/wnl.55.7.1052 · Cited by 252 · see citing works

[ 11 C]( R )-PK11195 PET imaging of microglial activation in multiple system atrophy

Gerhard, A., Banati, R. B., Goerres, G. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F., Good, C. D., Mathias, C. J., Quinn, N. P., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000078192.95645.e6 · Cited by 247 · see citing works

[ ¹¹ C] <i>(R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis</i>

Banati, R. B., Goerres, G. W., Myers, R., Gunn, R. N., Turkheimer, F. E., Kreutzberg, G. W., Brooks, D. J., Jones, T., & Duncan, J. S. (1999) · Neurology · doi:10.1212/wnl.53.9.2199 · Cited by 224 · see citing works

Surveillance, Intervention and Cytotoxicity: Is There a Protective Role of Microglia?

Banati, R. B., & Graeber, M. B. (1994) · Developmental Neuroscience · doi:10.1159/000112098 · Cited by 184 · see citing works

A software system for interactive and quantitative visualization of multidimensional biomedical images.

Robb, R. A., & Hanson, D. P. (1991) · PubMed · Cited by 179 · see citing works

In vivo visualization of activated glia by[11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion

Cagnin, A. (2001) · Brain · doi:10.1093/brain/124.10.2014 · Cited by 169 · see citing works

Physical characteristics of the ECAT EXACT3D positron tomograph

Spinks, T. J., Jones, T., Bloomfield, P. M., Bailey, D. L., Miller, M., Hogg, D., Jones, W. F., Vaigneur, K., Reed, J. L., Young, J., et al. (2000) · Physics in Medicine and Biology · doi:10.1088/0031-9155/45/9/313 · Cited by 155 · see citing works

In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration

Gerhard, A., Watts, J., Trender‐Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K. P., & Brooks, D. J. (2004) · Movement Disorders · doi:10.1002/mds.20162 · Cited by 145 · see citing works

In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke

Gerhard, A., Neumaier, B., Elitok, E., Glatting, G., Ries, V., Tomczak, R. J., Ludolph, A. C., & Reske, S. N. (2000) · Neuroreport · doi:10.1097/00001756-200009110-00025 · Cited by 136 · see citing works

Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury

Banati, R. B., Cagnin, A., Brooks, D. J., Gunn, R. N., Myers, R., Jones, T., Birch, R., & Anand, P. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00012 · Cited by 123 · see citing works

Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology

Rüb, U., Tredici, K. D., Schultz, C., Ghebremedhin, E., de Vos, R. A. I., Steur, E. N. H. J., & Braak, H. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00269-x · Cited by 121 · see citing works

Neuropathology of Parkinson’s Disease and Related Syndromes

Gibb, W. R. G. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30215-9 · Cited by 99 · see citing works

Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients

Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R., Brooks, D. J., & Duncan, J. S. (2003) · Brain · doi:10.1093/brain/awg138 · Cited by 90 · see citing works

CR3/43, a marker for activated human microglia: application to diagnostic neuropathology

Graeber, M. B., Bise, K., & Mehraein, P. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00987.x · Cited by 89 · see citing works

Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation?

Banati, R. B. (2002) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(02)00018-9 · Cited by 84 · see citing works

Estimation of the Number of “True” Null Hypotheses in Multivariate Analysis of Neuroimaging Data

Turkheimer, F., Smith, C. B., & Schmidt, K. (2001) · NeuroImage · doi:10.1006/nimg.2001.0764 · Cited by 79 · see citing works

Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice.

Wang, J., Asensio, V., & Campbell, I. (2002) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-662-09525-6_2 · Cited by 77 · see citing works

Lewy bodies in the cerebellar dentate nucleus of a patient with Parkinson's disease

Kakita, A., Takahashi, H., Homma, Y., et al. (1994) · Pathology International · doi:10.1111/j.1440-1827.1994.tb01688.x · Cited by 19 · see citing works

Erratum: In-vivo measurement of activated microglia in dementia (Lancet (461))

Cagnin, A. (2001) · The Lancet · Cited by 2 · see citing works

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1 · see citing works

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

Mechanisms underlying inflammation in neurodegeneration

Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · see citing works

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

The Role of Oxidative Stress in Parkinson's Disease

Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845 · see citing works

Microglia in neurodegeneration

Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710 · see citing works

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works

Inflammation and immune dysfunction in Parkinson disease

Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930 · see citing works

Neuroinflammation in Parkinson's disease and its potential as therapeutic target

Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884 · see citing works

Does neuroinflammation fan the flame in neurodegenerative diseases?

Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751 · see citing works

Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation

Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750 · see citing works

Glial reactions in Parkinson's disease

McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · see citing works

Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697 · see citing works

Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674 · see citing works

Colonic inflammation in Parkinson's disease

Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627 · see citing works

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585 · see citing works

Microbiome–microglia connections via the gut–brain axis

Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471 · see citing works

Parkinson disease and the immune system - Associations, mechanisms and therapeutics

Tan, E.-K., Chao, Y.-X., West, A., Chan, L.-L., Poewe, W., & Jankovic, J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0344-4 · Cited by 457 · see citing works

Microglial activation in presymptomatic Huntington's disease gene carriers

Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain · doi:10.1093/brain/awm044 · Cited by 440 · see citing works

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease

Gelders, G., Baekelandt, V., & Van der Perren, A. (2018) · Journal of Immunology Research · doi:10.1155/2018/4784268 · Cited by 430 · see citing works

Kynurenines in CNS disease: regulation by inflammatory cytokines.

Campbell, B. M., Charych, E., Lee, A. W., & Möller, T. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00012 · Cited by 409 · see citing works

MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406 · see citing works

Microglial activation and amyloid deposition in mild cognitive impairment: A PET study

Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367 · see citing works

Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

Scheiblich, H., Dansokho, C., Mercan, D., Schmidt, S. V., Bousset, L., Wischhof, L., Eikens, F., Odainic, A., Spitzer, J., Griep, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.007 · Cited by 360 · see citing works

Microglia Phenotypes in Aging and Neurodegenerative Diseases

Wendimu, M. Y., & Hooks, S. B. (2022) · Cells · doi:10.3390/cells11132091 · Cited by 336 · see citing works

Microglial Dynamics and Role in the Healthy and Diseased Brain: A Paradigm of Functional Plasticity

Gomez-Nicola, D., & Perry, V. H. (2015) · The Neuroscientist · doi:10.1177/1073858414530512 · Cited by 340 · see citing works

Neuroinflammation in Neurodegenerative Disorders-a Review

Schain, M., & Kreisl, W. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0733-2 · Cited by 301 · see citing works

Microglial phenotypes in Parkinson’s disease and animal models of the disease

Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285 · see citing works

Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease

Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256 · see citing works

Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease

Allen Reish, H. E., & Standaert, D. G. (2015) · Journal of Parkinson’s Disease · doi:10.3233/jpd-140491 · Cited by 244 · see citing works

Noninvasive Molecular Imaging of Neuroinflammation

Jacobs, A. H., Tavitian, B., & the INMiND consortium (2012) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2012.53 · Cited by 245 · see citing works

The methodology of TSPO imaging with positron emission tomography

Turkheimer, F. E., Rizzo, G., Bloomfield, P. S., Howes, O., Zanotti-Fregonara, P., Bertoldo, A., & Veronese, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150058 · Cited by 238 · see citing works

Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance

Passamonti, L., Tsvetanov, K. A., Jones, P. S., Bevan-Jones, W. R., Arnold, R., Borchert, R. J., Mak, E., Su, L., O'Brien, J. T., & Rowe, J. B. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2574-18.2019 · Cited by 220 · see citing works

Microglia in Parkinson's disease

Ho, M. S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_13 · Cited by 227 · see citing works

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease

George, S., Rey, N. L., Tyson, T., Esquibel, C., Meyerdirk, L., Schulz, E., Pierce, S., Burmeister, A. R., Madaj, Z., Steiner, J. A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0335-3 · Cited by 229 · see citing works

In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease

Iannaccone, S., Cerami, C., Alessio, M., Garibotto, V., Panzacchi, A., Olivieri, S., Gelsomino, G., Moresco, R. M., & Perani, D. (2013) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2012.07.002 · Cited by 221 · see citing works

TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control

Gatliff, J., East, D., Crosby, J., Abeti, R., Harvey, R., Craigen, W., Parker, P., & Campanella, M. (2014) · Autophagy · doi:10.4161/15548627.2014.991665 · Cited by 215 · see citing works

The role of free radicals in the aging brain and Parkinson’s Disease: Convergence and parallelism

Kumar, H., Lim, H.-W., More, S. V., Kim, B.-W., Koppula, S., Kim, I. S., & Choi, D.-K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810478 · Cited by 212 · see citing works

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205 · see citing works

Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease

Parbo, P., Ismail, R., Hansen, K. V., Amidi, A., Mårup, F. H., Gottrup, H., Brændgaard, H., Eriksson, B. O., Eskildsen, S. F., Lund, T. E., et al. (2017) · Brain · doi:10.1093/brain/awx120 · Cited by 199 · see citing works

Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans

Owen, D. R., Narayan, N., Wells, L., Healy, L., Smyth, E., Rabiner, E. A., Galloway, D., Williams, J. B., Lehr, J., Mandhair, H., et al. (2017) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x17710182 · Cited by 194 · see citing works

Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum

Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189 · see citing works

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases

Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182 · see citing works

Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics

Jurado-Coronel, J. C., Cabezas, R., Ávila Rodríguez, M. F., Echeverria, V., García-Segura, L. M., & Barreto, G. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.09.002 · Cited by 180 · see citing works

Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders

Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182 · see citing works

Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair

Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., & Ologunde, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.982795 · Cited by 171 · see citing works

Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides

Reglodi, D., Renaud, J., Tamas, A., Tizabi, Y., Socías, S. B., Del-Bel, E., & Raisman-Vozari, R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.004 · Cited by 162 · see citing works

Doxycycline Suppresses Microglial Activation by Inhibiting the P38 MAPK and NF-KB Signaling Pathways

Santa-Cecília, F. V., Socias, B., Ouidja, M. O., Sepulveda-Diaz, J. E., Acuña, L., Silva, R. L., Michel, P. P., Del-Bel, E., Cunha, T. M., & Raisman-Vozari, R. (2016) · Neurotoxicity Research · doi:10.1007/s12640-015-9592-2 · Cited by 165 · see citing works

Early microglial activation and peripheral inflammation in dementia with Lewy bodies

Surendranathan, A., Su, L., Mak, E., Passamonti, L., Hong, Y. T., Arnold, R., Vázquez Rodríguez, P., Bevan-Jones, W. R., Brain, S. A. E., Fryer, T. D., et al. (2018) · Brain · doi:10.1093/brain/awy265 · Cited by 154 · see citing works

Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation

Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156 · see citing works

Glycosphingolipids and Neuroinflammation in Parkinson’s Disease

Belarbi, K., Cuvelier, E., Bonte, M.-A., Desplanque, M., Gressier, B., Devos, D., & Chartier-Harlin, M.-C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00408-1 · Cited by 155 · see citing works

CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease

Zhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154 · see citing works

Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies

Kouli, A., Horne, C. B., & Williams-Gray, C. H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.042 · Cited by 143 · see citing works

Clinical Criteria for the Diagnosis of Parkinson’s Disease

Reichmann, H. (2010) · Neurodegenerative Diseases · doi:10.1159/000314478 · Cited by 145 · see citing works

A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis

Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138 · see citing works

Positron Emission Tomography Imaging of Neuroinflammation

Cagnin, A., Kassiou, M., Meikle, S. R., & Banati, R. B. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.04.006 · Cited by 137 · see citing works

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

Schröder, J. B., Pawlowski, M., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Meuth, S. G., Ruck, T., & Warnecke, T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01081 · Cited by 134 · see citing works

Enteric glial cells: New players in Parkinson's disease?

Clairembault, T., Leclair‐Visonneau, L., Neunlist, M., & Derkinderen, P. (2015) · Movement Disorders · doi:10.1002/mds.25979 · Cited by 117 · see citing works

[ ¹¹ C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy

Passamonti, L., Rodríguez, P. V., Hong, Y. T., Allinson, K. S. J., Bevan-Jones, W. R., Williamson, D., Jones, P. S., Arnold, R., Borchert, R. J., Surendranathan, A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005610 · Cited by 115 · see citing works

Microglial NLRP3 Inflammasome Activation Upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies

Scheiblich, H., Bousset, L., Schwartz, S., Griep, A., Latz, E., Melki, R., & Heneka, M. T. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100035 · Cited by 122 · see citing works

A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome

Morris, G., & Maes, M. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9324-8 · Cited by 117 · see citing works

Microglial activation in Parkinson’s disease using [18F]-FEPPA

Ghadery, C., Koshimori, Y., Coakeley, S., Harris, M., Rusjan, P., Kim, J., Houle, S., & Strafella, A. P. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0778-1 · Cited by 113 · see citing works

Imaging of microglia in patients with neurodegenerative disorders

Politis, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00096 · Cited by 111 · see citing works

Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model

Tentillier, N., Etzerodt, A., Olesen, M. N., Rizalar, F. S., Jacobsen, J., Bender, D., Moestrup, S. K., & Romero-Ramos, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-16.2016 · Cited by 109 · see citing works

Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies

López González, I., Garcia-Esparcia, P., Llorens, F., & Ferrer, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020206 · Cited by 101 · see citing works

TREM2 deficiency aggravates α‐synuclein–induced neurodegeneration and neuroinflammation in Parkinson's disease models

Guo, Y., Wei, X., Yan, H., Qin, Y., Yan, S., Liu, J., Zhao, Y., Jiang, F., & Lou, H. (2019) · The FASEB Journal · doi:10.1096/fj.201900992r · Cited by 101 · see citing works

Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment

Knezevic, D., & Mizrahi, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.007 · Cited by 97 · see citing works

The Role of Anti-Inflammatory Agents in Parkinson???s Disease

McGeer, E. G., & McGeer, P. L. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00001 · Cited by 95 · see citing works

Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine

Gulyás, B., Vas, Á., Tóth, M., Takano, A., Varrone, A., Cselényi, Z., Schain, M., Mattsson, P., & Halldin, C. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.020 · Cited by 94 · see citing works

Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice

Feng, Y.-K., Wu, Q.-L., Peng, Y.-W., Liang, F.-Y., You, H.-J., Feng, Y.-W., Li, G., Li, X.-J., Liu, S.-H., Li, Y.-C., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02027-5 · Cited by 87 · see citing works

Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases

Stanga, S., Caretto, A., Boido, M., & Vercelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103719 · Cited by 90 · see citing works

Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy

Hoffmann, A., Ettle, B., Battis, K., Reiprich, S., Schlachetzki, J. C. M., Masliah, E., Wegner, M., Kuhlmann, T., Riemenschneider, M. J., & Winkler, J. (2019) · Brain Pathology · doi:10.1111/bpa.12678 · Cited by 83 · see citing works

Translocator protein 18 kDa (TSPO) deficiency inhibits microglial activation and impairs mitochondrial function

Yao, R., Pan, R., Shang, C., Li, X., Cheng, J., Xu, J., & Li, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00986 · Cited by 79 · see citing works

<i>In vivo</i> imaging of microglial activation by positron emission tomography with <scp>[¹¹C]PBR28</scp> in the <scp>5XFAD</scp> model of <scp>A</scp>lzheimer's disease

Mirzaei, N., Tang, S. P., Ashworth, S., Coello, C., Plisson, C., Passchier, J., Selvaraj, V., Tyacke, R. J., Nutt, D. J., & Sastre, M. (2016) · Glia · doi:10.1002/glia.22978 · Cited by 82 · see citing works

Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging

Cerami, C., Iaccarino, L., & Perani, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050993 · Cited by 75 · see citing works

Microbiota‐microglia connections in age‐related cognition decline

Zhou, R., Qian, S., Cho, W. C. S., Zhou, J., Jin, C., Zhong, Y., Wang, J., Zhang, X., Xu, Z., Tian, M., et al. (2022) · Aging Cell · doi:10.1111/acel.13599 · Cited by 71 · see citing works

Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease

Garcia, P., Jürgens‐Wemheuer, W., Uriarte Huarte, O., Michelucci, A., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2022) · Glia · doi:10.1002/glia.24149 · Cited by 65 · see citing works

Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA

Suridjan, I., Rusjan, P. M., Voineskos, A. N., Selvanathan, T., Setiawan, E., Strafella, A. P., Wilson, A. A., Meyer, J. H., Houle, S., & Mizrahi, R. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.09.021 · Cited by 71 · see citing works

Glial Cells and Integrity of the Nervous System

von Bernhardi, R., Eugenín-von Bernhardi, J., Flores, B., & Eugenín León, J. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-40764-7_1 · Cited by 67 · see citing works

Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation

Huang, Q., Wang, Y., Chen, S., & Liang, F. (2023) · Aging and disease · doi:10.14336/ad.2023.0807 · Cited by 62 · see citing works

Widespread microglial activation in multiple system atrophy

Kübler, D., Wächter, T., Cabanel, N., Su, Z., Turkheimer, F. E., Dodel, R., Brooks, D. J., Oertel, W. H., & Gerhard, A. (2019) · Movement Disorders · doi:10.1002/mds.27620 · Cited by 61 · see citing works

Brain microglia activation and peripheral adaptive immunity in Parkinson’s disease: a multimodal PET study

Liu, S.-Y., Qiao, H.-W., Song, T.-B., Liu, X.-L., Yao, Y.-X., Zhao, C.-S., Barret, O., Xu, S.-L., Cai, Y.-N., Tamagnan, G. D., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02574-z · Cited by 62 · see citing works

Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series

Joers, V., Masilamoni, G., Kempf, D., Weiss, A. R., Rotterman, T. M., Murray, B., Yalcin-Cakmakli, G., Voll, R. J., Goodman, M. M., Howell, L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105027 · Cited by 56 · see citing works

Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model

Thi Lai, T., Kim, Y. E., Nguyen, L. T. N., Thi Nguyen, T., Kwak, I. H., Richter, F., Kim, Y. J., & Ma, H.-I. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00640-2 · Cited by 56 · see citing works

Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model

Scheffold, A., Holtman, I. R., Dieni, S., Brouwer, N., Katz, S.-F., Jebaraj, B. M. C., Kahle, P. J., Hengerer, B., Lechel, A., Stilgenbauer, S., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0364-x · Cited by 53 · see citing works

Disease progression-dependent expression of CD200R1 and CX3CR1 in mouse models of Parkinson's disease

Wang, L., Liu, Y., Yan, S., Du, T., Fu, X., Gong, X., Zhou, X., Zhang, T., & Wang, X. (2020) · Aging and disease · doi:10.14336/ad.2019.0615 · Cited by 49 · see citing works

Immune-mediated processes in neurodegeneration: where do we stand?

Fakhoury, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8052-0 · Cited by 43 · see citing works

Carnitine/Organic Cation Transporter OCTN1 Negatively Regulates Activation in Murine Cultured Microglial Cells

Ishimoto, T., Nakamichi, N., Nishijima, H., Masuo, Y., & Kato, Y. (2018) · Neurochemical Research · doi:10.1007/s11064-017-2350-5 · Cited by 36 · see citing works

Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration

Ernest James Phillips, T., & Maguire, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652593 · Cited by 33 · see citing works

Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by <scp>l</scp>‐DOPA in hemiparkinsonian rats

Bortolanza, M., do Nascimento, G. C., Raisman‐Vozari, R., & Del‐Bel, E. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15439 · Cited by 33 · see citing works

MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson’s disease

Wang, D., Gao, H., Qin, Q., Li, J., Zhao, J., Qu, Y., Li, J., Xiong, Y., Min, Z., Mao, Z., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04881-w · Cited by 25 · see citing works

Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease

Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24 · see citing works

MRI volume measurement of basal ganglia volumes in patients with Tourette's syndrome

Lu, J., Li, K., Cao, Y., Zhang, M., & Sui, X. (2009) · Zhonghua fangshexian yixue zazhi · doi:10.3760/cma.j.issn.1005-1201.2009.03.006 · Cited by 1 · see citing works

The Basal Ganglia

Chesselet, M., Cooper, G. M., & Rodnitzky, R. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-371-2_18

The relationship between metabolic control and basal ganglia morphometry and function in individuals with early-treated phenylketonuria

Brown, A. A., Clocksin, H. E., Abbene, E. E., Ursery, M., & Christ, S. E. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.09.006 · Cited by 9 · see citing works

Basal ganglia volumes following CO poisoning: A prospective longitudinal study.

Pulsipher, D. T., Hopkins, R., & Weaver, L. K. (2006) · PubMed · Cited by 31 · see citing works

Simultaneous Bilateral Basal Ganglia Hemorrhage

Yang, Z., Chen, J., & Mu, J. (2016) · Current Drug Delivery · doi:10.2174/1567201813666160607202811 · Cited by 14 · see citing works